<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen YS</submitter><funding>Leona M. and Harry B. Helmsley Charitable Trust</funding><funding>HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>NIDDK NIH HHS</funding><funding>American Diabetes Association</funding><funding>Diabetes Research Connection</funding><funding>JDRF</funding><pagination>e2103518118</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8325334</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>118(30)</volume><pubmed_abstract>Insulin-signaling requires conformational change: whereas the free hormone and its receptor each adopt autoinhibited conformations, their binding leads to structural reorganization. To test the functional coupling between insulin's "hinge opening" and receptor activation, we inserted an artificial ligand-dependent switch into the insulin molecule. Ligand-binding disrupts an internal tether designed to stabilize the hormone's native closed and inactive conformation, thereby enabling productive receptor engagement. This scheme exploited a diol sensor (&lt;i>meta&lt;/i>-fluoro-phenylboronic acid at Gly&lt;sup>A1&lt;/sup>) and internal diol (3,4-dihydroxybenzoate at Lys&lt;sup>B28&lt;/sup>). The sensor recognizes monosaccharides (fructose > glucose). Studies of insulin-signaling in human hepatoma-derived cells </pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Insertion of a synthetic switch into insulin provides metabolite-dependent regulation of hormone-receptor activation.</pubmed_title><pmcid>PMC8325334</pmcid><funding_grant_id>R01 DK127761</funding_grant_id><funding_grant_id>R01 DK040949</funding_grant_id><funding_grant_id>Project number 21</funding_grant_id><funding_grant_id>1-08-RA-149</funding_grant_id><funding_grant_id>3-PDF-2017-380-A-N</funding_grant_id><funding_grant_id>7-13-IN-31</funding_grant_id><funding_grant_id>2017PG-T1D007</funding_grant_id><pubmed_authors>Lawrence MC</pubmed_authors><pubmed_authors>Weiss MA</pubmed_authors><pubmed_authors>Chatterjee D</pubmed_authors><pubmed_authors>Dhayalan B</pubmed_authors><pubmed_authors>Jarosinski MA</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Phillips NB</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Chen YS</pubmed_authors><pubmed_authors>Gleaton J</pubmed_authors><pubmed_authors>Michael MD</pubmed_authors><pubmed_authors>Broadwater L</pubmed_authors><pubmed_authors>Hattier T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Insertion of a synthetic switch into insulin provides metabolite-dependent regulation of hormone-receptor activation.</name><description>Insulin-signaling requires conformational change: whereas the free hormone and its receptor each adopt autoinhibited conformations, their binding leads to structural reorganization. To test the functional coupling between insulin's "hinge opening" and receptor activation, we inserted an artificial ligand-dependent switch into the insulin molecule. Ligand-binding disrupts an internal tether designed to stabilize the hormone's native closed and inactive conformation, thereby enabling productive receptor engagement. This scheme exploited a diol sensor (&lt;i>meta&lt;/i>-fluoro-phenylboronic acid at Gly&lt;sup>A1&lt;/sup>) and internal diol (3,4-dihydroxybenzoate at Lys&lt;sup>B28&lt;/sup>). The sensor recognizes monosaccharides (fructose > glucose). Studies of insulin-signaling in human hepatoma-derived cells </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jul</publication><modification>2026-05-08T10:39:19.271Z</modification><creation>2022-02-11T16:14:04.015Z</creation></dates><accession>S-EPMC8325334</accession><cross_references><pubmed>34290145</pubmed><doi>10.1073/pnas.2103518118</doi></cross_references></HashMap>